Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview
Explore Ironwood Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
577.2M
P/E Ratio
23.91
EPS (TTM)
$0.15
ROE
-0.08%
IRWD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ironwood Pharmaceuticals, Inc. (IRWD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.12.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.91 and a market capitalization of 577.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.